Abstract P2-15-14: Triple negative (TNBC) metastatic breast cancer (MBC) patients (pts): Is chemotherapy (CHT) choice influenced by adjuvant (adj) treatments? Results from the GIM-13 AMBRA study
Giorgio Mustacchi(University of Trieste), Ornella Garrone(Azienda Sanitaria Ospedaliera S.Croce e Carle Cuneo), Clara Natoli(Kliniken Essen-Mitte), Monica Giordano(Ospedale Sant'Anna), Grazia Arpino(University of Naples Federico II), Antônio Bernardo(Fondazione Salvatore Maugeri), P. Pronzato(Accademia Nazionale dei Lincei), Marina Elena Cazzaniga(Azienda Ospedaliera San Gerardo), Paolo Marchetti(Istituto Dermopatico dell'Immacolata), Alessandra Beano(Presidio Ospedaliero), Alessandra Fabi(Agostino Gemelli University Polyclinic), Lorenzo Livi(European Society for Sexual Medicine), Laura Biganzoli(Hospital of Prato), Lucrezia Diodati(Azienda Ospedaliera Universitaria Pisana), Marta Riemma(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Anna Turletti(Ospedale Martini), Livio Blasi, Andrea Milani(Nerviano Medical Sciences), Ferdinando Riccardi(Ospedale Antonio Cardarelli), Alessia D’Alonzo(Ospedale Policlinico San Martino)
Cited by 0
Related Papers
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
|Annals of Oncology|2016|2.1k
5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)
|Annals of Oncology|2020|1.4k
4th ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)
|Annals of Oncology|2018|1.2k